Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:
Go back to Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:| Quantum Technology Corp (NASDAQ: QNTM) | Delayed: 3.55 +0.09 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.46 | 52 Week High | $2.00 | |||
| Open | $3.52 | 52 Week Low | $0.10 | |||
| Day High | $3.84 | P/E | N/A | |||
| Day Low | $3.47 | EPS | $0.00 | |||
| Volume | 474,954 | |||||
